Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Authors' reply.
Department of Medicine, Center for Innovation in Access and Quality, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA; GI Health, Outcomes, Policy and Economics (GI-HOPE) Program, Division of Gastroenterology, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA. justin.sewell@ucsf.edu.
J L
JL
Sewell
S C
SC
Shah
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology*
D000900:Anti-Bacterial Agents